Additionally, the 36-month beta value for PGEN is 1.61. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for PGEN is 162.74M and currently, short sellers hold a 13.26% ratio of that float. The average trading volume of PGEN on March 14, 2025 was 2.10M shares.
PGEN) stock’s latest price update
The stock price of Precigen Inc (NASDAQ: PGEN) has plunged by -2.25 when compared to previous closing price of 1.78, but the company has seen a -6.95% decline in its stock price over the last five trading sessions. prnewswire.com reported 2025-03-13 that GERMANTOWN, Md., March 13, 2025 /PRNewswire/ — Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will release full year 2024 financial results and provide business updates on Wednesday, March 19, 2025.
PGEN’s Market Performance
Precigen Inc (PGEN) has seen a -6.95% fall in stock performance for the week, with a 2.35% gain in the past month and a 116.66% surge in the past quarter. The volatility ratio for the week is 7.18%, and the volatility levels for the past 30 days are at 10.43% for PGEN. The simple moving average for the past 20 days is -5.38% for PGEN’s stock, with a 40.99% simple moving average for the past 200 days.
Analysts’ Opinion of PGEN
Cantor Fitzgerald gave a rating of “Overweight” to PGEN, setting the target price at $7 in the report published on November 18th of the previous year.
PGEN Trading at 14.48% from the 50-Day Moving Average
After a stumble in the market that brought PGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.82% of loss for the given period.
Volatility was left at 10.43%, however, over the last 30 days, the volatility rate increased by 7.18%, as shares sank -8.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +139.57% upper at present.
During the last 5 trading sessions, PGEN fell by -6.95%, which changed the moving average for the period of 200-days by +29.85% in comparison to the 20-day moving average, which settled at $1.8390. In addition, Precigen Inc saw 55.36% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PGEN starting from Perez Jeffrey Thomas, who purchase 58,823 shares at the price of $0.85 back on Aug 09 ’24. After this action, Perez Jeffrey Thomas now owns 743,097 shares of Precigen Inc, valued at $50,000 using the latest closing price.
KIRK RANDAL J, the Director of Precigen Inc, purchase 23,529,411 shares at $0.85 during a trade that took place back on Aug 09 ’24, which means that KIRK RANDAL J is holding 64,547,214 shares at $19,999,999 based on the most recent closing price.
Stock Fundamentals for PGEN
Current profitability levels for the company are sitting at:
- -32.78 for the present operating margin
- -0.63 for the gross margin
The net margin for Precigen Inc stands at -35.22. The total capital return value is set at -2.09. Equity return is now at value -137.46, with -101.81 for asset returns.
Based on Precigen Inc (PGEN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -13.17. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -9992.69.
Currently, EBITDA for the company is -89.23 million with net debt to EBITDA at 0.14. When we switch over and look at the enterprise to sales, we see a ratio of 123.8. The receivables turnover for the company is 5.44for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.63.
Conclusion
In conclusion, Precigen Inc (PGEN) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
